Information For Referring Physicians

At the present time, patients may be referred for evaluation of:

1. Glut-1 DS (glucose transporter type-1 deficiency syndrome)
2. MELAS (mitochondrial encephalopathy, lactic acidosis and stroke-like episodes)
3. MERRF (mitochondrial encephalomyopahy with ragged-red fibers)
4. Pyruvate dehydrogenase deficiency
5. Pyruvate carboxylase deficiency

All referrals must be sent by pediatric neurologists at the request of patients and parents.  Initial enquiries and correspondence after receipt of referral information may be held via electronic mail at: giblinlabs@neuro.columbia.edu

Referral information must be sent by mail from a physician’s office and must include:

* Referring physician contact information, including e-mail

* Patient insurance and contact information

* Brief clinical summary (limit one page)

* Copies of complementary explorations’ reports; in particular, results of cerebrospinal fluid analysis, neuroimaging, electroencephalography and related techniques.

Upon review of this information, if warranted, further documentation and blood samples of the patient and immediate relatives may be requested.  None of the items received will be returned.  Therefore, copies should be provided.

Mailing address:

Dr. Darryl De Vivo
Colleen Giblin Laboratories
Neurological Institute
710 West 168^th Street
New York, NY 10032

Disclaimer

The results of this evaluation may not be considered for clinical use and will be provided only on a research basis.  They are not intended to supersede or modify the clinical judgment of the referring or treating physicians.

The Colleen Giblin Laboratories, staff, its funding and supporting institutions will not be liable for any consequences derived from the knowledge or use of any information provided to the involved health professionals or to the individuals studied.